Nava 

₹560.20
15
+₹3.20+0.57% Friday 09:59

統計

當日最高
560.35
當日最低
559.5
52週高點
739.4
52週低點
501.65
成交量
526
平均成交量
-
市值
158.75B
本益比
21.65
股息殖利率
0.98%
股息
5.5

即將到來

股息

0.98%股息殖利率
Aug 26
₹5.50
Nov 25
₹3.00
Aug 25
₹6.00
Sep 24
₹2.00
Aug 24
₹2.00
10年成長
18.94%
5年成長
不適用
3年成長
41.5%
1年成長
83.33%

財報

5Nov預期
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
下一步
999
333
-333
-999
預期EPS
不適用
實際EPS
不適用

財務

18.43%利潤率
有盈利
2020
2021
2022
2023
2024
2025
42.69B營收
7.87B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 NAVA.NSE 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Established in 1972 and headquartered in Hyderabad, India, Nava Limited operates as a diversified international enterprise with core activities spanning power generation, mining, ferro alloys manufacturing, and healthcare services. Its global reach extends to India, Zambia, Hong Kong, Japan, and Singapore, among other markets. In its power division, the company produces and sells electricity from various fuel sources, including coal, biomass, biogas, and bagasse. Its significant power assets in India include 150 MW and 114 MW plants in Paloncha, Telangana; a 150 MW facility in Kharagprasad, Odisha; and a 20 MW biomass plant in Dharmavaram, Andhra Pradesh. Internationally, it runs a 300 MW thermal power plant in Zambia, while also offering operation and maintenance expertise for power facilities. The mining segment is engaged in coal extraction at Maamba in Zambia's Southern province. Its ferro alloys business manufactures a variety of specialized metals, such as ferro chrome, silico manganese, ferro silicon, and other chromium alloys, which are crucial components in the automotive, railway, and construction industries, as well as in the production of stainless-steel consumer products. Nava's healthcare ventures include the management of The Iron Suites Medical Center in Singapore, specializing in the treatment of iron deficiency and the administration of intravenous iron. This division also oversees corporate healthcare programs, organizes medical conferences and public awareness campaigns, and is involved in licensing pharmaceutical products. Formerly known as Nava Bharat Ventures Limited, the company rebranded to Nava Limited in July 2022.
Show more...
執行長
Ashwin Devineni
員工
1249
國家
印度
ISIN
INE725A01030

上市

0 Comments

分享你的想法

FAQ

Nava 今天的股價是多少?
NAVA.NSE 目前價格為 ₹560.20 INR,過去 24 小時上漲了 +0.57%。在圖表上更密切關注 Nava 股價表現。
Nava 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 NSE (India) 交易所,Nava 的股票以代號 NAVA.NSE 進行交易。
Nava 的股價在上漲嗎?
NAVA.NSE 股票較上週下跌 -1.11%,本月下跌 -5.72%,過去一年 Nava 下跌 -17.45%。
Nava 的市值是多少?
今天 Nava 的市值為 158.75B
Nava 下一次財報日期是什麼時候?
Nava 將於 November 05, 2026 公布下一次財報。
Nava 去年的營收是多少?
Nava 去年的營收為 42.69BINR。
Nava 去年的淨利是多少?
NAVA.NSE 去年的淨收益為 7.87BINR。
Nava 會發放股息嗎?
是的,NAVA.NSE 的股息每 年度 發放一次。每股最新股息為 5.5 INR。截至今日,股息殖利率(FWD)% 為 0.98%。
Nava 有多少名員工?
截至 September 06, 2026,公司共有 1,249 名員工。
Nava 位於哪個產業?
Nava從事於Manufacturing產業。
Nava 何時完成拆股?
Nava 上次拆股發生於 January 20, 2025,比例為 2:1。
Nava 的總部在哪裡?
Nava 的總部位於 印度 的 Hyderabad。